UCB CEO warns Europe it can't declare biopharma a strategic industry and not pay up
This article was originally published in Scrip
Executive Summary
European governments can't have it both ways: declaring on the one hand that biopharma is a strategic industry and then on the other shying away from paying to give their citizens access to innovative medicines. This was the stark warning from Roch Doliveux, CEO of UCB.